StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Viking Therapeutics (VKTX) Trades Higher in Sympathy with Madrigal Pharma (MDGL)
May 31, 2018 7:14 AM
Viking Therapeutics (NASDAQ: VKTX) traded higher in sympathy with peer ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Viking Therapeutic (VKTX) PT Raised to $15 at Laidlaw
June 1, 2018 12:57 PM
Madrigal Pharmaceuticals (MDGL) PT Raised to $313 at H.C. Wainwright; 'Likely Takeout Premium'
June 1, 2018 7:05 AM
Viking Therapeutic (VKTX) PT Raised to Street High $15 at H.C. Wainwright
June 1, 2018 7:03 AM
Viking Therapeutics (VKTX) Adds to Earlier Gains, Up 100%
May 31, 2018 3:12 PM
UPDATE: Viking Therapeutic (VKTX) PT Raised to $14 at Maxim Group; 'What's Good for Madrigal is Good for Viking'
May 31, 2018 12:03 PM
While Intercept (ICPT) NASH Competitor 'Impresses', ICPT Remains Ahead and is Undervalued - RBC
May 31, 2018 11:30 AM
Madrigal Pharma (MDGL) Doubles on Positive NASH Trial Results
May 31, 2018 9:46 AM
Madrigal Pharma (MDGL) Phase 2 Clinical Trial of MGL-3196 for Patients with NASH Demonstrated Statistical Significance in Primary Endpoint
May 31, 2018 6:55 AM
Madrigal’s MGL-3196 Achieves Liver Biopsy Endpoints in Patients with Non-alcoholic Steatohepatitis (NASH) at 36 Weeks in Phase 2 Clinical Trial
May 31, 2018 6:50 AM
